As of 2024-07-27, the Relative Valuation of Bio Rad Laboratories Inc (BIO) is (358.04) USD. This relative valuation is based on P/E multiples. With the latest stock price at 319.42 USD, the upside of Bio Rad Laboratories Inc based on Relative Valuation is -212.1%.
The range of the Relative Valuation is (342.95) - (384.55) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 30.3x - 34.7x | 31.8x |
| Forward P/E multiples | 28.6x - 34.0x | 31.6x |
| Fair Price | (342.95) - (384.55) | (358.04) |
| Upside | -207.4% - -220.4% | -212.1% |
| Date | P/E |
| 2024-07-26 | -28.26 |
| 2024-07-25 | -27.88 |
| 2024-07-24 | -27.42 |
| 2024-07-23 | -27.00 |
| 2024-07-22 | -26.71 |
| 2024-07-19 | -26.26 |
| 2024-07-18 | -26.56 |
| 2024-07-17 | -28.19 |
| 2024-07-16 | -27.82 |
| 2024-07-15 | -26.73 |
| 2024-07-12 | -26.91 |
| 2024-07-11 | -26.14 |
| 2024-07-10 | -24.80 |
| 2024-07-09 | -24.32 |
| 2024-07-08 | -24.32 |
| 2024-07-05 | -24.50 |
| 2024-07-03 | -23.89 |
| 2024-07-02 | -23.67 |
| 2024-07-01 | -23.35 |
| 2024-06-28 | -24.16 |
| 2024-06-27 | -24.06 |
| 2024-06-26 | -24.60 |
| 2024-06-25 | -24.79 |
| 2024-06-24 | -25.11 |
| 2024-06-21 | -25.48 |
| 2024-06-20 | -25.27 |
| 2024-06-18 | -25.57 |
| 2024-06-17 | -26.17 |
| 2024-06-14 | -24.97 |
| 2024-06-13 | -24.93 |
| 2024-06-12 | -25.06 |
| 2024-06-11 | -24.87 |
| 2024-06-10 | -25.16 |
| 2024-06-07 | -25.39 |
| 2024-06-06 | -25.57 |
| 2024-06-05 | -25.58 |
| 2024-06-04 | -25.52 |
| 2024-06-03 | -25.56 |
| 2024-05-31 | -25.38 |
| 2024-05-30 | -24.95 |
| 2024-05-29 | -25.21 |
| 2024-05-28 | -25.31 |
| 2024-05-24 | -25.41 |
| 2024-05-23 | -25.68 |
| 2024-05-22 | -25.82 |
| 2024-05-21 | -25.61 |
| 2024-05-20 | -25.82 |
| 2024-05-17 | -26.00 |
| 2024-05-16 | -26.16 |
| 2024-05-15 | -26.63 |